• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2015.07a
• /
• pp.366-368
• /
• 2015

광양항은 4개의 항로가 설정되어 있다. 광양항 제1항로는 광양항 항계에서 "해사안전법" 제10조에 따른 교통안전특정해역(여수구역)과 연결되어 있고, 낙포각 사포부두(원유부두 북측) 전면 해상에서 광양항 제2항로와 광양항 제3항로 및 제4항로가 분기 합류된다. 이 글은 광양항 제1항로에서 제2항로로 진입하고 있던 선박과 광양항 제3항로에서 제1항로로 진입하고 있던 선박 사이에 발생한 충돌사건의 개요와 원인을 살펴보고, 개항내 항로가 분기 합류되는 수역에서 합의항법이 적용될 수 있는 점과 현행 광양항 항로의 재배치 필요성, 여수지방해양항만청 고시로 규정하고 있는 광양항내 안전한 속력을 광양항에 입출항하는 모든 선장 및 항해사가 알 수 있도록 해도 및 "Guide to Port Entry"에 반영할 것, 그리고 VTS관제사가 광양항에 입출항하는 선박이 안전한 속력을 준수하도록 권고 또는 지시 필요성 등의 교훈 및 개선사항을 제시하고 있다.

• Proceedings of the Korean Institute of Navigation and Port Research Conference
• /
• 2013.06a
• /
• pp.539-541
• /
• 2013

울산 신항 남항지구에 설치되는 SPM은 설치 위치와 공사의 특성상 제4항로 전면을 일정 기간 잠식함과 더불어 상당히 광범위한 공사구간이 요구됨으로써 제4항로 통항 선박 및 공사구간을 통항하는 선박들의 통항 안전 및 작업선들의 작업 안전에 대한 대책 마련이 필요한 바 이 연구에서는 제4항로의 임시항로 설정과 임시항로의 통항안전성 평가가 더불어 통항 선박 및 작업선의 해상교통 안전대책을 수립하였다.

• Proceedings of KOSOMES biannual meeting
• /
• 2017.11a
• /
• pp.4-4
• /
• 2017

• Journal of Legislation Research
• /
• no.54
• /
• pp.217-259
• /
• 2018

The Trust Act, which was first enacted back in 1961, was fully revised on 25. July 2011 and enacted on 26. July 2012. The Act is a fundamental norm governing trust relation, so the revision was expected to play an important role to promote trust institutions. However many problems were also revealed after the enactment. The Act has already inherent limitations because the previous discussions were not enough and the amendment process was not meticulously reviewed. Now it is needed to consider the comprehensive amendment of the Act reflecting detailed legal doctrines developed hitherto by the courts and the legal academia. This paper aims to call for the revision of the Act and to propose the ways and the grounds for revision. The purpose of the revision is to rectify obvious errors on several provisions, to minimize legal uncertainty by presenting detailed rules on many issues, to enhance the coherence and consistency between the rules along with supplementing the relevant laws, and to strike a proper balance between the parties.

• Korea Petroleum Association Journal
• /
• no.7 s.29
• /
• pp.98-99
• /
• 1983

석유사업법 시행령 제 15조 제3항 및 제 4항의 규정에 의한 수입금의 납부 및 환급에 관한 요령

• KOREAN POULTRY JOURNAL
• /
• v.37 no.4 s.426
• /
• pp.65-67
• /
• 2005

종계장$\cdot$부화장의 효율적 방역관리와 추백리$\cdot$가금티푸스의 사전예방을 통해 양계농가에 건강한 병아리를 공급하기 위하여 가축전염병예방법 제3조제2항$\cdot$제15조제1항 및 제16조제1항의 규정에 따라 종계장$\cdot$부화장방역관리요령이 지난 12월 6일 고시되어 오는 5월1일 시행을 앞두고 있다.

• Tuberculosis and Respiratory Diseases
• /
• v.66 no.3
• /
• pp.198-204
• /
• 2009

Background: First-line drugs, if sensitive, are the most potent drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB). This study examined the frequency and risk factors associated with acquired drug resistance to first-line drugs during a standardized treatment using first-line drugs in patients with MDR-TB. Methods: This study included patients who were diagnosed with MDR-TB at the National Masan Tuberculosis Hospital between January 2004 and May 2008, treated with standardized first-line drugs, and for whom the preand post-treatment results of the drug susceptibility test were available. Their medical records were reviewed retrospectively. Results: Of 41 MDR-TB patients, 14 (34.1%) acquired additional resistance to ethambutol (EMB) or pyrazinamide (PZA). Of 11 patients initially resistant to isoniazid (INH) and rifampicin (RFP), 3 (27.3%) acquired additional resistance to both EMB and PZA, and 3 (27.3%) to PZA. Of 18 patients initially resistant to INH, RFP and EMB, 6 (33.3%) acquired additional resistance to PZA. Of 6 patients initially resistant to INH, RFP and PZA, 2 (33.3%) acquired additional resistance to EMB. Ten of the 41 MDR-TB patients (24.4%) changed from resistant to susceptible. No statistically significant risk factors associated with acquired resistance could be found. Conclusion: First-line drugs should be used cautiously in the treatment of MDR-TB in Korea considering the potential acquisition of drug resistance.

• Microbiology and Biotechnology Letters
• /
• v.42 no.2
• /
• pp.207-210
• /
• 2014

Viral infections are capable of inducing reactive oxygen species (ROS) production in the infected cells and antioxidants have been reported to have antiviral activities against many viruses. In this study, an antiviral assay using the cytopathic effect (CPE) reduction method revealed that gallic acid possesses good anti-coxsackievirus B3 (CB3) and coxsackievirus B4 (CB4) activities, reducing the formation of visible CPE. However, ribavirin did exhibit weak anti-CB3 and CB4 activities and was unable to prevent CPE. Therefore, we conclude that the inhibition of CB3 or CB4 production by gallic acid may be due to its general action as an antioxidant.

• 월간 기계설비
• /
• s.313
• /
• pp.46-47
• /
• 2016

정부는 하도급대금 및 건설기계대여대금 체불로 인한 하도급업체 및 건설기계대여업체의 피해를 예방하기 위해 지난 2월 3일 건설산업기본법 제34조 제7항 및 제68조의3 제6항을 개정하고 8월 4일부터 시행키로 했다. 이에 따라 국가 지방자치단체 및 공공기관 발주자는 8월 4일부터 하도급대금 지급보증서 및 건설기계대여대금 지급보증서의 교부 여부를 의무적으로 확인해야 한다.

• Korean Journal of Clinical Laboratory Science
• /
• v.53 no.2
• /
• pp.137-142
• /
• 2021

This study investigated the patterns of acquiring anti-mycobacterial resistance in individuals who were susceptible to all anti-mycobacterial drugs in their initial treatment. From 2010 to 2019, anti-mycobacterial drug susceptibility tests were conducted on patients who were referred to the Green Cross Laboratories. The test results of 594 anti-mycobacterial drug sensitivity tests were collected at 111 medical institutions. The first test results had 594 cases in which all anti-mycobacterial drugs were susceptible. Isoniazid (INH), rifampin (RIF), streptomycin (SM), and quinolone (QUI) showed the highest single-resistant conversion rates. Out of 56 patients, 17 patients (30.4%) showed a high conversion rate of resistance to both INH and RIF. The tracking period was analyzed from a minimum of 98 days to 1,862 days, and an average of 435.6 days for INH, and a minimum of 108 days to 1,673 days, with an average of 457.7 days for RIF. In the case of tuberculosis patients who are susceptible to all anti-mycobacterial drugs, it is considered that the conversion to resistant and multi-drug resistant tuberculosis (MDR-TB) must be confirmed through an anti-mycobacterial susceptibility test after 3 months. It is hoped that this study will help the national tuberculosis management project to improve public health.